| Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) (NCT00790907) | GlaxoSmithKline | 2009-02-01 |
| The Effects of Potassium Nitrate in Reducing Dentinal Hypersensitivity (NCT01587950) | GlaxoSmithKline | 2009-02-01 |
| GSK1349572 Mass Balance Study (NCT00828763) | GlaxoSmithKline | 2009-02-01 |
| A Follow-up Survey to Compare Stable Dosing (SERETIDE) With SYMBICORT, SMART, Maintenance and Reliever Therapy in One Inhaler in Moderate and Severe Asthmatics. (NCT00858286) | GlaxoSmithKline | 2009-02-01 |
| A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes (NCT00838916) | GlaxoSmithKline | 2009-02-01 |
| Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes (NCT00838903) | GlaxoSmithKline | 2009-02-01 |
| A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage Forms (NCT01550926) | GlaxoSmithKline | 2009-02-01 |
| Prevalence of Chronic Airway Obstruction in Subjects With a History of Cigarette Smoking in a Primary Care Setting (NCT01013948) | GlaxoSmithKline | 2009-02-01 |
| A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes (NCT00839527) | GlaxoSmithKline | 2009-02-01 |
| Observational Study of Nelarabine in Children and Young Adults (NCT00866671) | GlaxoSmithKline | 2009-02-01 |
| Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II (NCT01304238) | GlaxoSmithKline | 2009-02-01 |
| Study to Evaluate the Pharmacodynamics of SB-656933 in Patients With Ulcerative Colitis (NCT00748410) | GlaxoSmithKline | 2009-01-22 |
| Drug Interaction Study Between Eltrombopag and Lopinavir/Ritonavir in Healthy Adult Subjects. (NCT00833378) | GlaxoSmithKline | 2009-01-19 |
| A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects (NCT00823940) | GlaxoSmithKline | 2009-01-13 |
| Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years (NCT00802464) | GlaxoSmithKline | 2009-01-12 |
| Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults (NCT00814489) | GlaxoSmithKline | 2009-01-08 |
| Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6-12wks of Age (NCT00808444) | GlaxoSmithKline | 2009-01-05 |
| Analysis of Trends Over Time of Hepatitis Related Incidence in Panama (NCT01159951) | GlaxoSmithKline | 2009-01-01 |
| Safety and Efficacy Study of Albiglutide in Type 2 Diabetes (NCT00849017) | GlaxoSmithKline | 2009-01-01 |
| Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL) (NCT00802737) | GlaxoSmithKline | 2009-01-01 |
| Safety and Efficacy of Albiglutide in Type 2 Diabetes (NCT00849056) | GlaxoSmithKline | 2009-01-01 |
| Phase 2, Pharmacokinetics Study of Eltrombopag in Japanese Thrombocytopenic Subjects With Chronic Liver Disease (NCT00861601) | GlaxoSmithKline | 2009-01-01 |
| Fosamprenavir in Pts With Hepatic Impairment (NCT01054586) | GlaxoSmithKline | 2009-01-01 |
| A Study to Evaluate the Effect of Antacid and Multivitamin and Mineral Tablet on the Study Drug GSK1349572 (NCT00858455) | GlaxoSmithKline | 2009-01-01 |
| Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Canada or the US (NCT00799825) | GlaxoSmithKline | 2009-01-01 |
| Effect of Dentifrice Usage Regime on Delivery and Efficacy of Fluoride (NCT01563172) | GlaxoSmithKline | 2009-01-01 |
| Trends Over Time (1990-2010) of Diarrhoea-related Incidence, Hospitalizations and Deaths in Children of Panama (NCT01171144) | GlaxoSmithKline | 2009-01-01 |
| Drug Interaction Study to Investigate Co-administration of GW642444M With Ketoconazole (NCT00866515) | GlaxoSmithKline | 2008-12-22 |
| Effects of the D3 Antagonist GSK598809 on Food Reward and Reinforcement (NCT01039454) | GlaxoSmithKline | 2008-12-18 |
| Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine (NCT00805389) | GlaxoSmithKline | 2008-12-15 |
| A First Time in Human Study in Healthy Volunteers to Investigate a New Medicine to Treat Malaria (NCT00811356) | GlaxoSmithKline | 2008-12-11 |
| Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma (NCT00843193) | GlaxoSmithKline | 2008-12-09 |
| An Open Label Positron Emission Tomography (PET) Study of GSK618334 in Healthy Male Subjects Using 11C-PHNO as PET Ligand (NCT00814957) | GlaxoSmithKline | 2008-12-08 |
| Vaccination Course in Primed Children and Age-matched Unprimed Children With Pneumococcal Vaccine GSK1024850A (NCT00792909) | GlaxoSmithKline | 2008-12-02 |
| A Phase III Study to Test the Benefit of a New Kind of Anti-cancer Treatment in Patients With Melanoma, After Surgical Removal of Their Tumor (NCT00796445) | GlaxoSmithKline | 2008-12-01 |
| Study in Mild Asthmatic Patients (NCT00748306) | GlaxoSmithKline | 2008-12-01 |
| Migraine Study in Adolescent Patients (NCT00843024) | GlaxoSmithKline | 2008-12-01 |
| Trends Over Time (1990-2010) of Diarrhoea-related Hospitalizations and Deaths in Children < 5 Years of Age in Brazil (NCT01175252) | GlaxoSmithKline | 2008-12-01 |
| Dose Response of a Tubule Occlusion Agent (NCT01075256) | GlaxoSmithKline | 2008-12-01 |
| Special Drug Use Investigation for ARIXTRA (Fondaparinux) Abdominal (Urology,Obstetrics,Gynecology) (NCT01390883) | GlaxoSmithKline | 2008-12-01 |
| A Study Investigating the Pharmacokinetic Profiles of Four Extended Release Paracetamol Formulations (NCT01568749) | GlaxoSmithKline | 2008-12-01 |
| Drug Use Investigation for LAMICTAL (NCT01376180) | GlaxoSmithKline | 2008-12-01 |
| Evaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy (NCT00791518) | GlaxoSmithKline | 2008-12-01 |
| A Study to Evaluate the Efficacy and Safety of Fondaparinux for the Prevention of Venous Blood Clots in Patients With a Plaster Cast or Other Type of Immobilization for a Below-knee Injury Not Needing Surgery (NCT00843492) | GlaxoSmithKline | 2008-12-01 |
| Relapse Prevention Study in Newly Abstinent Smokers (NCT00793468) | GlaxoSmithKline | 2008-12-01 |
| Study to Evaluate GSK2190915 in Subjects With Mild Asthma (NCT00812773) | GlaxoSmithKline | 2008-12-01 |
| A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD). (NCT00784550) | GlaxoSmithKline | 2008-12-01 |
| United States Pharmacovigilence Retapamulin-Prescribing (NCT01153880) | GlaxoSmithKline | 2008-12-01 |
| A Clinical Trial to Test a Study Drug in Volunteers Who Develop Asthma Following Exercise (NCT00812929) | GlaxoSmithKline | 2008-12-01 |
| The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial (NCT00799903) | GlaxoSmithKline | 2008-12-01 |
| Proof of Mechanism in ELT (NCT00861484) | GlaxoSmithKline | 2008-11-26 |
| Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants (NCT00779779) | GlaxoSmithKline | 2008-11-22 |
| W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers (NCT01915758) | GlaxoSmithKline | 2008-11-21 |
| First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160. (NCT00849134) | GlaxoSmithKline | 2008-11-17 |
| A First-Time-In-Human Study in Healthy Subjects (NCT00857883) | GlaxoSmithKline | 2008-11-17 |
| A Study for Evaluation of GSK Biologicals' Pandemic Influenza Vaccine. (NCT00812981) | GlaxoSmithKline | 2008-11-15 |
| Single Dose Escalation First Time in Human PK Study (NCT00828867) | GlaxoSmithKline | 2008-11-14 |
| Safety and Tolerability of Repeat Dosing of GSK233705/GW642444 in COPD (NCT00749411) | GlaxoSmithKline | 2008-11-13 |
| A Study to Assess the Safety and Pharmacokinetics of Inhaled Doses of GSK233705 and GW642444 in Healthy Subjects (NCT00783003) | GlaxoSmithKline | 2008-11-10 |
| Clinical Study in Children, 6 Months to 3 Years of Age, to Assess Two Dose Levels of an Experimental Flu Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control (NCT00778895) | GlaxoSmithKline | 2008-11-10 |
| Intranasal SB-705498 in Healthy Volunteers (NCT00907933) | GlaxoSmithKline | 2008-11-10 |
| A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses. (NCT00989625) | GlaxoSmithKline | 2008-11-04 |
| Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. (NCT00774995) | GlaxoSmithKline | 2008-11-01 |
| Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma (NCT00911196) | GlaxoSmithKline | 2008-11-01 |
| In Situ Caries Model of Fluoride Toothpastes (NCT01005966) | GlaxoSmithKline | 2008-11-01 |
| An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks (NCT00695305) | GlaxoSmithKline | 2008-11-01 |
| A Study to Determine the Effect of Sumatriptan and Naproxen Sodium Combination Tablet, Sumatriptan Tablet, and Naproxen Sodium Tablet on Blood Pressure When Treating Migraine Headaches That Occur During a 6-month Period (NCT00792636) | GlaxoSmithKline | 2008-11-01 |
| EU PV for Retapamulin-Prescribing (NCT01153828) | GlaxoSmithKline | 2008-11-01 |
| Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration (NCT00758264) | GlaxoSmithKline | 2008-10-30 |
| Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects (NCT00779766) | GlaxoSmithKline | 2008-10-22 |
| A Study To Investigate Safety, Blood Levels And Effects Of Giving GW642444, By Mouth, By Inhalation & By Injection (NCT00711126) | GlaxoSmithKline | 2008-10-21 |
| The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers (NCT00718666) | GlaxoSmithKline | 2008-10-20 |
| First Time in Human Study (FTIH) With Positron Emission Tomography (PET) (NCT01381419) | GlaxoSmithKline | 2008-10-20 |
| Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older (NCT00765076) | GlaxoSmithKline | 2008-10-16 |
| Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years (NCT00771615) | GlaxoSmithKline | 2008-10-16 |
| Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly (NCT00772889) | GlaxoSmithKline | 2008-10-09 |
| Evaluation of Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Years and Older (NCT00760617) | GlaxoSmithKline | 2008-10-06 |
| A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder (NCT00733980) | GlaxoSmithKline | 2008-10-02 |
| Pazopanib Versus Placebo in Patients With Soft Tissue Sarcoma Whose Disease Has Progressed During or Following Prior Therapy (NCT00753688) | GlaxoSmithKline | 2008-10-01 |
| Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children (NCT00764790) | GlaxoSmithKline | 2008-10-01 |
| GSK1349572 Drug Interaction Study With Protease Inhibitors (NCT00774735) | GlaxoSmithKline | 2008-10-01 |
| Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma (NCT00766090) | GlaxoSmithKline | 2008-10-01 |
| GSK1349572 Drug Interaction Study With Etravirine (NCT00774111) | GlaxoSmithKline | 2008-10-01 |
| Evaluation of the Duration of Oral Combination Therapy in Type 2 Diabetes, Prior to the Initiation of Insulin in the UK (NCT00995995) | GlaxoSmithKline | 2008-10-01 |
| A Study to Assess the Safety and Tolerability of Once Daily Inhaled Doses of GSK573719 Made With Magnesium Stearate in Subjects With Chronic Obstructive Pulmonary Disease(COPD)for 7 Days (NCT00732472) | GlaxoSmithKline | 2008-10-01 |
| Evaluation of a New Anti-cancer Immunotherapy After Chemotherapy in Adult Patients With Acute Myeloid Leukemia (AML) (NCT00725283) | GlaxoSmithKline | 2008-10-01 |
| Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 (NCT00751348) | GlaxoSmithKline | 2008-10-01 |
| MAGE-A3 Antigen-Specific Cancer Immunotherapeutic in Patients With Progressive Metastatic Cutaneous Melanoma (NCT00706238) | GlaxoSmithKline | 2008-09-29 |
| EtOH Interaction Study (NCT00887367) | GlaxoSmithKline | 2008-09-29 |
| A First Time In Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GSK1399686 (NCT00721812) | GlaxoSmithKline | 2008-09-25 |
| A Study of GW685698X in Healthy Japanese Male Subjects (NCT00972673) | GlaxoSmithKline | 2008-09-24 |
| Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors (NCT00732420) | GlaxoSmithKline | 2008-09-24 |
| Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants (NCT00753649) | GlaxoSmithKline | 2008-09-23 |
| Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. (NCT00733551) | GlaxoSmithKline | 2008-09-23 |
| Phase I Study of GSK233705 in Healthy Japanese Male Subjects (NCT00964405) | GlaxoSmithKline | 2008-09-20 |
| Phase I Study of GW642444M in Healthy Japanese Male Subjects (NCT00964249) | GlaxoSmithKline | 2008-09-20 |
| Ofatumumab in Japanese Patients With CD20 Positive Follicular Lymphoma or Chronic Lymphocytic Leukemia (NCT00742144) | GlaxoSmithKline | 2008-09-19 |
| Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic (NCT01424384) | GlaxoSmithKline | 2008-09-19 |
| Evaluation of Pneumococcal Vaccine Formulations in Elderly (NCT00756067) | GlaxoSmithKline | 2008-09-19 |
| A Study to Assess the Safety and Reactogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (Cervarix) in Healthy Female Filipino Subjects Vaccinated According to the Prescribing Information From the Age of 10 Years Onwards. (NCT00730847) | GlaxoSmithKline | 2008-09-17 |